DJIA 17,598.20 -91.66 -0.52%
NASDAQ 5,115.38 -12.90 -0.25%
S&P 500 2,098.04 -5.80 -0.28%
market minute promo

49.60 -1.05 (-2.07%)

Quote as of

Extended Hours: $49.60 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ENTA $49.60 -2.07%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.50
Previous Close $50.65
Daily Range $49.31 - $51.89
52-Week Range $30.13 - $52.58
Market Cap $927.1M
P/E Ratio 8.37
Dividend (Yield) $0.00 (0.0%)
Volume 301,279
Average Daily Volume 370,603
Current FY EPS $4.86

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

News & Commentary Rss Feed

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Enanta Pharmaceuticals (ENTA) Jumps: Stock Rises 5.1% - Tale of the Tape

Enanta Pharmaceuticals (ENTA) Jumps: Stock Rises 5.1% - Tale of the Tape

Enanta Pharmaceuticals (ENTA) Flagged As Strong On High Volume

Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE (ombitasvir, paritaprevir and

Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE (ombitasvir, paritaprevir and ritonavir) tablets

Insider Trading Alert - ENTA, BFS And PAYX Traded By Insiders

Short-Sellers Betting Against These Biotechs

5 Free Cash All-Stars With Guru Strategy Approval

5 NASDAQ Healthcare Stocks With The Highest ROA

Five Free-Cash All-Stars With Guru Strategy Approval

US Stock Futures Gain Ahead Of Economic Data

Enanta Pharmaceuticals Announces the Appointment of Nathalie Adda, M.D. as Chief Medical Officer

See More ENTA News...